Very early researchStudy completedNCT02265861What this trial is testingResponse of VEGF and AT-II to HCG in PCOSWho this might be right forPolycystic Ovary Syndrome Nanjing University School of Medicine 60
Testing effectiveness (Phase 2)UnknownNCT05775874What this trial is testingEvaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCWho this might be right forUrothelial Carcinoma Abbisko Therapeutics Co, Ltd 80
Testing effectiveness (Phase 2)UnknownNCT01732276What this trial is testingThe Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast CancerWho this might be right forBreast Cancer Jiangmen Central Hospital 50
Not applicableUnknownNCT05051592What this trial is testingRole of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer PatientsWho this might be right forColorectal Cancer National University Hospital, Singapore 40
Testing effectiveness (Phase 2)Ended earlyNCT04024436What this trial is testingTAS-120 in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast CancerFGFR 1 High AmplificationFGFR2 Amplification Taiho Oncology, Inc. 64
Early research (Phase 1)Looking for participantsNCT06756932What this trial is testingBGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast CancerWho this might be right forHormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer BeOne Medicines 120
Large-scale testing (Phase 3)Ended earlyNCT01905592What this trial is testingA Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsWho this might be right forNeoplasms, BreastCarcinoma of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast+3 more Tesaro, Inc. 216
Not applicableUnknownNCT00903292What this trial is testingTailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaWho this might be right forNon-Small Cell Lung Cancer National Cheng-Kung University Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT07330544What this trial is testingA Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine TherapyWho this might be right forBreast Cancer Zhejiang Cancer Hospital 118
Not applicableWithdrawnNCT00907699What this trial is testingLaboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507Who this might be right forLung Cancer Case Comprehensive Cancer Center
Not applicableStudy completedNCT05376644What this trial is testingMolecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3Who this might be right forBreast Cancer Female Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857What this trial is testingTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Who this might be right forMetastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more RayzeBio, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT07699328What this trial is testingVRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung CancerWho this might be right forEGFR-Mutant Non-Small Cell Lung Cancer Voronoi, Inc 315
Early research (Phase 1)Study completedNCT01322802What this trial is testingVaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerWho this might be right forStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial Cancer+1 more University of Washington 25
Not applicableStudy completedNCT00911781What this trial is testingHemangioma Growth During the First 6 Months of LifeWho this might be right forHemangiomas of Infancy University of California, San Francisco 36
Testing effectiveness (Phase 2)Study completedNCT01401166What this trial is testingParticipant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast CancerWho this might be right forBreast Neoplasms Hoffmann-La Roche 488
Testing effectiveness (Phase 2)Ended earlyNCT01184053What this trial is testingTrisenox® in Women With Metastatic Endometrial CancerWho this might be right forEndometrial Carcinoma UNC Lineberger Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400What this trial is testingLearn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsWho this might be right forBreast CancerSolid Tumors Pfizer 235
Not applicableNot Yet RecruitingNCT07659912What this trial is testingDirect Versus Video Laryngoscopy in Patients With AcromegalyWho this might be right forAcromegalyNonfunctioning Pituitary Adenoma Muzaffer GENCER 40
Early research (Phase 1)Ended earlyNCT01288430What this trial is testingDS-2248 in Participants With Advanced Solid TumorsWho this might be right forSolid TumorsNon-small Cell Lung Carcinoma Daiichi Sankyo 60